Article Information
History
- November 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Rebecca M Pollak1,*,
- Jordan E Pincus2,3,4,*,
- T Lindsey Burrell2,
- Joseph F Cubells5,6,
- Cheryl Klaiman2,3,
- Melissa M Murphy2,
- Celine A Saulnier2,7,
- Elaine F Walker8,
- Stormi Pulver White2,3 and
- Jennifer G Mulle1,9,†
- 1Center for Advanced Biotechnology and Medicine, Robert Wood Johnson Medical School, Rutgers University
- 2Department of Pediatrics, School of Medicine, Emory University
- 3Marcus Autism Center, Children’s Healthcare of Atlanta and Emory University School of Medicine
- 4Clinical Psychology, College of Arts & Sciences, Georgia State University
- 5Department of Human Genetics, School of Medicine, Emory University
- 6Department of Psychiatry and Behavioral Science, School of Medicine, Emory University
- 7Neurodevelopmental Assessment & Consulting Services
- 8Department of Psychology, Emory University
- 9Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University
- ↵†Corresponding author information:
Jennifer Gladys Mulle, MHS, PhD; Center for Advanced Biotechnology and Medicine and Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, 679 Hoes Lane West, Piscataway, NJ 08854; 848-445-9866; jennifer.mulle{at}rutgers.edu
↵* Denotes equal contribution
Posted November 02, 2022.
The clinical phenotype of autism spectrum disorder in individuals with 3q29 deletion syndrome
